We use deep sequencing to identify sources of variation in mRNA splicing in the dorsolateral prefrontal cortex (DLFPC) of 450 subjects from two prospective cohort studies of aging. Hundreds of aberrant pre-mRNA splicing events are reproducibly associated with Alzheimer's Disease (AD). We also generate a catalog of splicing quantitative trait loci (sQTL) effects in the human cortex: splicing of 3,198 genes is influenced by genetic variation. sQTLs are enriched among those variants influencing DNA methylation and histone acetylation. In assessing known AD loci, we report that altered splicing is the mechanism for the effects of the PICALM, CLU, and PTK2B susceptibility alleles. Further, we leverage our sQTL catalog to identify genes whose aberrant splicing is associated with AD and mediated by genetics. This transcriptomewide association study identified 21 genes with significant associations, many of which are found in AD GWAS loci, but 8 are in novel AD loci, including FUS, which is a known amyotrophic lateral sclerosis (ALS) gene. This highlights an intriguing shared genetic architecture that is further elaborated by the convergence of old and new AD genes in autophagy-lysosomal-related pathways already implicated in AD and other neurodegenerative diseases. Overall, this study of the aging brain's transcriptome provides evidence that dysregulation of mRNA splicing is a feature of AD and is, in some genetically-driven cases, causal.
INTRODUCTION
of variants are mapped to splice acceptor sites and 16.4% to splice donor sites. The remaining (23.2%) mapped to other splice regions or are found within an intron ( Supplementary Fig. 3 ). Further, sQTLs are mapped to distinct regulatory features as defined by 15 chromatin states in DLPFC 25 : sQTLs were significantly enriched in actively transcribed regions and enhancers. They are depleted in repressed chromatin marked with polycomb, heterochromatin, and quiescent regions (Fig. 3a) .
To assess the extent of sQTL replication, we compared our sQTLs to the recently published dataset from the CommonMind Consortium (CMC), consisting of DLFPC profiles from 258 persons with schizophrenia and 279 control subjects 26 (see Supplementary Notes). Our sQTLs yield a Storey's π 1 = 0.78 in the CMC data, suggesting substantial sharing of sQTLs between these two different brain collections (Fig. 3b) . Moreover, 93% of sQTLs showed the same direction of effect (Fig. 3b) . The fraction of sQTLs that are novel deserve further evaluation to assess the extent to which they may be context-specific given that the average age at death of our participants is 88 years.
In agreement with recent findings in lymphoblastoid cell lines (LCLs) 20 , we found that a majority of sQTLs act independent of gene expression effect, as evident by the low degree of sharing between sQTLs and eQTLs 27 from the same brains (π 1 = 0.18) (Fig. 3c) . Of the 9,045 lead sQTL SNPs, only 42 are also a lead eQTL, suggesting that a substantial fraction of sQTLs are unique and are not detected by standard eQTL analysis.
To further understand the mechanisms underlying sQTLs, we assessed the overlap of sQTLs with SNPs influencing epigenomic marks (xQTLs) such as DNA methylation (mQTL) and histone H3 acetylation on lysine 9 (H3K9Ac, haQTL) 27 that are available from the same DLPFC samples (Online Methods). Indeed, we found that such xQTLs 27 are significantly enriched among sQTLs when compared to randomly selected, matched SNPs (Kolmogorov-Smirnov test P < 0.001 ( Fig. 3d) : of the lead sQTL, 9% (578) and 19% (1246) were also associated with haQTL and mQTL, respectively, suggesting extensive genetic co-influences on splicing, methylation, and histone modifications. Finally, we found significant sharing of sQTL SNP among SNP that also influence histone (π 1 = 0.74) or methylation (π 1 = 0.82). These overlaps suggest a contribution of epigenomic regulation in directing splicing.
Given prior reports 20, 28 , we evaluated whether our sQTLs from the aging brain were enriched for AD susceptibility variants (Figs. 3e and 3f). We also assessed enrichment of AD SNPs (P < 1 x 10 -5 ) in splicing, methylation or expression QTLs from DLFPC 27 , monocytes 15, 29 , neutrophils 29 and T-cells 15, 29 . Using an enrichment method that uses permutation testing (matching for MAF, distance to TSS, and a number of LD proxies), we found that DLFPC sQTLs are more likely to be enriched among AD GWAS SNPs (P <10 5 ), followed by sQTL and eQTL from monocytes ( Fig. 3f) . These findings suggest the important role of RNA splicing on variation in AD susceptibility, the prominent role of myeloid cells in AD susceptibility 15 but also the fact that a number of AD variants have mechanisms that may be mediated through non-myeloid effects.
Some of these effects of AD variants on splicing are known, such as the 8-fold increase in full-length CD33 isoform 16, 30 and the SPI1 functional consequence 31 , but several of these -in CLU, PICALM, and PTK2B -have not been previously reported (Supplementary Table 6 ). For example, the PTK2B risk allele leads to increased skipping of exon 31 (chr8: 27308560-27308595) which contains a coding part of the gene (Fig. 5d) . These results delineate the initial events along the cascade of functional consequences for these three AD variants and provide important mechanistic insights into their development as potential therapeutic targets.
Splicing regulators associated with alternative splicing in DLFPC
Splicing of pre-mRNA is catalyzed by a large ribonucleoprotein complex called the spliceosome, which consists of five small nuclear RNAs (snRNA) and numerous splicing . We found that binding targets of 18 RBPs are significantly enriched among lead sQTLs (Fig. 4a) . The most enriched RBP is PTBP1 (Fisher's exact P < 0.006), followed by HNRNPC, CPSF7, and ELAVL1. Notably, the enrichment for neuronal ELAVL1 RBP target sites is consistent with a recent report that, upon neuronal ELAVL1 depletion,
BIN1
and PICALM transcripts were found to have lower exon inclusion for those sites in which ELAVL binding sites directly overlapped with SNPs associated with AD
34
.
On the other hand, we also observed significant enrichment for the lead sQTL SNPs within the binding sites for a number of heterogeneous nuclear ribonucleoproteins (hnRNP) including hnRNP C (P < 0.009). Further, we find that the expression levels of hnRNP splicing factors are correlated with intronic excision levels of hundreds of genes, many of which are in AD susceptibility loci including BIN1, PICALM, APP, and CLU Figs. 4 and 5) . The hnRNP C factor has been linked to AD in previous studies, including in a recent biochemical study reporting the translational regulation of APP mRNA by hnRNP C
(Supplementary

35
. This observation goes towards the mechanism of the sQTL: consistent with the assumption that, altering the sequence of a binding site changes the likelihood that a splicing event occurs in vivo. In one example of a sQTL affecting intron usage, a TBC1D7 (one of the new AD genes described in a later section; Figs. 6a and 6b) SNP is found within CLIP-defined binding sites for hnRNP C as well as other RBPs (Fig. 4b) To replicate these results, we first assessed whether using the expression imputation model built using the CMC dataset 26 that was deployed in IGAP AD GWAS yields significant results. We focused on the 21 significantly associated genes above:
five genes (CR1, PTK2B, CLU, TBC1D7, and AP2A2) replicated at FDR < 0.05 and two genes (MTCH2 and PICALM) were nominally significant at P < 0.05 with the expression and splicing inference from CMC (Fig. 5b) . The directions of effect for all six associations were consistent in both datasets (Fig. 5b) . Thus, we see robust replication, and our results are not due to the unique properties of the ROSMAP dataset. Second, we used the UK BioBank (UKBB) AD GWAS by proxy 39 to replicate the IGAP TWAS results. We note that, despite analyzing data from 116,196 subjects, the UKBB AD GWAS is underpowered since the GWAS does not use AD cases but, rather, subjects who have a first-degree relative with AD as "cases". Nevertheless, we were able to replicate (at nominal P < 0.05) seven of our IGAP TWAS associations in the UKBB TWAS (Fig. 5c ). These two complementary replication efforts demonstrate the robustness of our results. Finally, we performed a TWAS using the summary statistics of a meta-analysis of IGAP and UKBB GWAS, and identified three additional genes (ABCA7, RHBDF1, and VPS53) that meet a genome-wide significant threshold in the meta-analysis (Supplementary Table 7) , with ABCA7 being one of the well-validated AD loci.
Most of the TWAS associations are the result of differential intron usage, suggesting the importance of pre-mRNA splicing in AD (Fig. 5a ). An example of TWAS association with intron usage at PTK2B, a known AD susceptibility locus, is shown in Fig. 5d . We often observed multiple TWAS-associated genes in the same locus, likely due to co-expression of genes in close physical proximity or allelic heterogeneity within the susceptibility locus
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. . These new and known AD susceptibility genes are directly connected (i.e., they form shared 'communities') (P < 0.006) (Fig. 6c) . Further, this joint network is enriched for endocytosis pathways (P < 0.0002), highlighting the existing narrative of endocytosis pathways being preferentially targeted in AD. More interesting is the enrichment for the autophagy-lysosomal related pathway (P < 0.003) (Fig. 6c) . The genes in the autophagy-lysosomal related pathway (AP2A2, AP2A1, and MAP1B) form a statistically significant P < 4.3x10
) PPI sub-network with known AD genes (PTK2B, PICALM and BIN1) (Fig. 6d) . Protein degradation pathways have been implicated previously in ALS 43 and to a limited extent in AD
44
. Overall, these PPI analyses suggest that our new TWAS-derived genes are not a random set of genes but are part of an AD network.
DISCUSSION
In this study, we directly examined alternative splicing events in a large dataset of aging brains, which led to both the observation that specific alternative splicing events are reproducibly associated with AD and the functional dissection of genetic associations to AD. Our replication efforts demonstrate that the observed AD-related perturbations in splicing are not simply due to spliceosomal failure. Further, our in vitro model of tau overexpression in iPSC-derived neurons shows that perturbation of MAPT is sufficient to cause these disease-related splicing changes that are observed in the human cortex at autopsy. Finally, since these neurons are functionally normally, we now know that these splicing changes occur very early in the series of molecular events that are caused by perturbation in MAPT expression.
We combined this splicing map of the aging brain with common genetic variants and cataloged the genetic architecture controlling local splicing events. These analyses revealed a preponderance of brain and myeloid splicing events as being the functional consequence of AD susceptibility alleles, which connects with the broader AD-related splicing changes to highlight the role of altered RNA maturation as playing a key role in this neurodegenerative disease (Figs. 3f and 5a; Supplementary Table 6 ).
To address the issue of causality in results derived from our cross-sectional brain data, we used the powerful TWAS approach, which leverages our splicing map and common genetic variants to test the hypothesis that the effect of such variants in AD is mediated, by altering splicing levels. These analyses confirmed many of the known AD Our study also offers insights for several well-known AD loci in which the gene was known but the functional mechanism remained unclear. Similar to our work in CD33
16
, the careful analysis of these cortical data highlights a specific splicing mechanism for the AD risk alleles at CLU, PICALM, and PTK2B. All three are complex proteins with a large number of exons, so our results prioritize specific domains in these proteins as harboring the functional domain that influences AD risk. These domains will be critical in beginning to assemble a protein:protein interaction scaffold for AD susceptibility that goes beyond repurposing existing databases of interactions that are assessed in
GeNets. Further, our analyses of RBP involved in splicing regulation of AD susceptibility genes including PICALM and RNA binding site analysis of HNRNPC ( Fig. 4c; population stratification artifacts in the genetic analyses, the study was limited to non-Latino whites.
See Supplementary Notes for the details of CommonMind Consortium (CMC) and Mount Sinai Brain Bank (MSBB) datasets.
Data acquisition, quality control, and normalization
Genotyping. DNA from ROS and MAP subjects was extracted from whole blood, lymphocytes or frozen post-mortem brain tissue and genotyped on the Affymetrix GeneChip 6.0 platform at the Broad Institute's Center for Genotyping. Only self-declared non-Latino Caucasians were genotyped to minimize population heterogeneity. PLINK software 48 was used to implement our QC pipeline. We applied standard QC measures for subjects (genotype success rate >95%, genotype-derived gender concordant with reported gender, excess inter/intra-heterozygosity) and for single nucleotide polymorphisms (SNPs) (HWE P > 0.001; MAF > 0.01, genotype call rate > 0.95; misshap test > 1x10 -9 ) to these data. Subsequently, EIGENSTRAT 49 was used to identify and remove population outliers using default parameters. Imputation was performed using Michigan Imputation Server with Minimac3 50 using Haplotype Reference Consortium ancestry. Imputation filtering of r 2 > 0.3 was used for quality control. After QC, 450 individuals and 8,383,662 genotyped or imputed markers were used for sQTL analysis.
RNA-Seq data. RNA was sequenced from the gray matter of dorsal lateral prefrontal cortex (DLPFC) of 542 samples, corresponding to 540 unique brains. These samples were extracted using Qiagen's miRNeasey mini kit and the RNase free DNase Set. RNA was quantified using
Nanodrop. The quality of RNA was evaluated by the Agilent Bioanalyzer. All samples were chosen to pass two initial quality filters: RNA integrity (RIN) score >5 and quantity threshold of 5 μ g (and were selected from a larger set of 724 samples). RNA-Seq library preparation was performed using the strand specific dUTP method14 with poly-A selection. Sequencing was The RNA-Seq data were processed by a parallelized pipeline. This pipeline includes trimming the beginning and ending bases from each read, identifying and trimming adapter sequences from reads, detecting and removing rRNA reads, and aligning reads to reference genome.
Specifically, RNA-Seq reads in FASTQ format were inspected using FASTQC program.
Barcode and adapter contamination, low-quality regions (8bp at beginning and 7bp at ending of each FASTQ reads) were trimmed using FASTX-toolkit. To remove rRNA contamination, we aligned trimmed reads to rRNA reference (rRNA genes were downloaded from UCSC genome browser selecting the RepeatMask table) by BWA then extracted only paired unmapped reads for transcriptome alignment. STAR (v2.5) 52 (was used to align reads to the transcriptome reference, and RSEM (v1.3.0) 53 was used to estimate expression levels for all transcripts. To quantify the contribution of experimental and other confounding factors to the overall expression profiles, we used the COMBAT algorithm 54 to account for the effect of batch and linear regression to remove the effects of RIN, post-mortem interval (PMI), sequencing depth, study index (ROS sample or MAP sample), genotyping PCs, age at death, and sex. Finally, only highly expressed genes were kept (mean expression >2 log 2 -FPKM), resulting in 13,484
expressed genes for eQTL analysis. The details for cis-eQTL analysis are in Ng et al. (1) removed introns that were supported with fewer than 100 reads or fewer than 5% of the total number of intronic read counts for the entire cluster, and (2) re-clustered introns according to the procedure above. The intron usage ratio for each clusters was next computed and standardized (across individuals) and quantile normalized (across sample) as in Li et al. 20 .
Intron usage mapping and quantification. We used LeafCutter
Association of intron usage with AD and neuropathology traits. The association analysis
with neuropathology traits and intron usage was performed using a linear model, adjusting for experimental batch, RNA integrity number (RIN), sex, age at death, and post-mortem interval (PMI). To test for association with AD, we limited the comparison to those participants clinical diagnosis of AD and those who have neither diagnosis (Supplementary Table 1 ). We used
Leafcutter to identify intron clusters with at least one differentially excised intron by jointly modeling intron clusters using a Dirichlet-multinomial GLM 19 . To account for neuronal loss and cell type proportion in each brain sample, we used gene expression level of cell type specific genes as an additional covariate. However, these measures did not affect our association analysis. We report differentially spliced introns at Bonferroni-corrected P < 0.05 to correct for multiple hypothesis testing.
We used variancePartition 55 to estimate the proportion of variance explained of differently excised introns association with AD, burden of amyloid, burden of tangles, and neuritic plaques.
Splicing QTL mapping. We used Leafcutter to obtain the proportion of intron defining reads to the total number of reads from the intron cluster it belongs to. This intron ratio describes how often an intron is used relative to other introns in the same cluster. We used WASP 56 to remove read-mapping biases caused by allele-specific reads. This is particularly significant when a variant is covered by reads that also span intron junctions as it can lead to a spurious association between the variant and intron excision level estimates. Q-Q plots show quantiles of one dataset against quantiles of a second dataset and are commonly used in GWAS to show a departure from an expected P-value distribution. We generated Q-Q plots for LD-pruned GWAS SNPs (PLINK with the settings "--indep-pairwise 100 5 0.8"). We compared the sQTLs overlapping with LD-pruned GWAS SNPs and compared the distribution to a random set of SNPs with similar MAF.
GWAS Datasets.
We performed transcriptome-wide association study using GWAS summary statistics from: (1) (FDR 0.05) . Genes for which evidence of significant differential intron usage are highlighted in blue. In green, we highlight those genes where the TWAS using total gene expression are significant. (b) Replication of ROSMAP TWAS in CMC DLFPC data. The red triangles denote genes where the replication analysis is signific Replication of IGAP AD TWAS using the UK BioBank AD GWAS based on an independent set of subjects. (d) PTK2B gene structure (top): clu differential splicing events are noted with the colored curves. The panel then zooms to highlight differential intronic usage for chr8:27308412-27 stratified by rs2251430 genotypes (right). On the left, we show the same data use a box plot. (e) Conditional analysis of IGAP AD GWAS results for two effects for PTK2B and CLU in AD GWAS data. As noted in the top aspect of the panel, these two AD genes are located close to one another. The excision events for PTK2B and CLU are present in both ROSMAP (blue) and in CMC (green) dataset. When the AD GWAS is conditioned on the (chr8:27308412-27308560) splicing effect, the CLU effect remained significant, demonstrating its independence from the PTK2B association (superio plot where each dot is one SNP in the genomic segment under evaluation). The reciprocal analysis conditioning on the CLU (chr8:27461909:27462441 the PTK2B association remained significant. ). (c) The product of three of the novel AD genes ( AP2A1, and MAP1B) are members of the same PPI network (P < 0.006). The genes in this network and others not in the network (i.e., TBC1D7, PAC RABEP1) are significantly enriched in genes annotated as being involved in endocytosis (blue; P < 0.0002) and autophagy-related pathways (gree 0.003). (d) The novel AD genes (AP2A2, AP2A1, and MAP1B) form a significant PPI sub-network (P < 4.3 x10 -4 ) with known AD genes (i.e., PICALM and PTK2B).
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